PD-1 inhibitor Clinical Trials
22 recruitingDrug
Phase 211Phase 34Early Phase 13Not Applicable3Phase 12
Showing 1–20 of 22 trials
Recruiting
Phase 2
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Stomach NeoplasmsGastric Adenocarcinoma
Jinbo Yue54 enrolled1 locationNCT07007182
Recruiting
Phase 3
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University452 enrolled1 locationNCT06964568
Recruiting
Phase 2
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer
Neoadjuvant TherapyLocally Advanced Rectal Cancer
Fudan University192 enrolled1 locationNCT06281405
Recruiting
Phase 1Phase 2
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaHypofractionated Radiotherapy
West China Hospital84 enrolled4 locationsNCT07182565
Recruiting
Phase 1Phase 2
Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma
ChemotherapyGastroesophageal Junction AdenocarcinomaImmunotherapy+1 more
West China Hospital88 enrolled4 locationsNCT07072351
Recruiting
Phase 2Phase 3
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric or Gastroesophageal Junction Adenocarcinoma
Beijing Biostar Pharmaceuticals Co., Ltd.778 enrolled10 locationsNCT06841679
Recruiting
Early Phase 1
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital20 enrolled1 locationNCT06496373
Recruiting
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
Hepatocellular Carcinoma
Fudan University50 enrolled1 locationNCT07100405
Recruiting
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
Xinqiao Hospital of Chongqing20 enrolled1 locationNCT05486650
Recruiting
Phase 2
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University83 enrolled1 locationNCT06977074
Recruiting
Early Phase 1
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine60 enrolled1 locationNCT06980155
Recruiting
Early Phase 1
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Ruijin Hospital34 enrolled1 locationNCT05916248
Recruiting
Not Applicable
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
Hepatocellular CarcinomaSystemic TherapyPortal Vein Tumor Thrombus
Sun Yat-sen University42 enrolled1 locationNCT06622031
Recruiting
Phase 2
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751901
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06752044
Recruiting
Not Applicable
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06752057
Recruiting
Phase 2
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751849
Recruiting
Phase 3
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
Esophageal Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences436 enrolled1 locationNCT06086457
Recruiting
Phase 2
Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
Esophageal Neoplasm MetastaticEsophageal Cancer Stage IVb
Cancer Institute and Hospital, Chinese Academy of Medical Sciences120 enrolled1 locationNCT06084897
Recruiting
Phase 2
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Chondrosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University70 enrolled1 locationNCT05193188